H Lundbeck A/S (OTC Pink - Current Information:HLUYY)

56.64
Delayed Data
As of Apr 23
 0.00 / 0.00%
Today’s Change
46.05
Today|||52-Week Range
66.67
+11.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$11.0B

Company Description

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Contact Information

H. Lundbeck A/S
Ottiliavej 9
Valby Capital Region 2500
P:(453) 630-1311
Investor Relations:
(453) 643-2426

Employees

Shareholders

Other institutional0.08%
Mutual fund holders0.06%
Individual stakeholders--

Top Executives

Anders GötzscheExecutive VP, Chief Executive & Financial Officer
Lars BangExecutive VP-Supply Operations & Engineering
Anders Gersel PedersenExecutive Vice President-Research & Development
Jacob TolstrupExecutive Vice President-Commercial Operations
Jørn Møller MayntzhusenDirector & Senior Manager-Supply Optimization